|
Concurrent use of anti-VEGF and anti-EGFR antibodies in the treatment of metastatic colorectal cancer: a meta-analysis of randomized controlled trials |
Qian W, Chen G, Zhang Y, Zhu W, Li Z, Cai Q |
|
|
Record Status This is a systematic review that meets the criteria for inclusion on DARE. Bibliographic details Qian W, Chen G, Zhang Y, Zhu W, Li Z, Cai Q. Concurrent use of anti-VEGF and anti-EGFR antibodies in the treatment of metastatic colorectal cancer: a meta-analysis of randomized controlled trials. Chinese Journal of Cancer Biotherapy 2014; 21(1): 79-85 Indexing Status Subject indexing assigned by CRD MeSH Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Colorectal Neoplasms; Disease Progression; Disease-Free Survival; Humans; Molecular Targeted Therapy; Neoplasm Metastasis; Proportional Hazards Models; Receptor, Epidermal Growth Factor; Treatment Outcome; Vascular Endothelial Growth Factor A AccessionNumber 12014025874 Date bibliographic record published 10/12/2014 |
|
|
|